Trevi Therapeutics
TRVI
#7889
Rank
A$0.32 B
Marketcap
$4.25
Share price
-3.85%
Change (1 day)
100.74%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$58.65 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$44.41 Million a decrease over its 2022 earnings that were of -A$43.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$58.65 Million32.06%
2023 -A$44.41 Million2.43%
2022 -A$43.36 Million-14.45%
2021 -A$50.68 Million1.36%
2020 -A$50 Million23.64%
2019 -A$40.44 Million27.54%
2018 -A$31.71 Million